Published in Genet Epidemiol on January 01, 2002
Recent developments in genomewide association scans: a workshop summary and review. Am J Hum Genet (2005) 3.76
PPC: an algorithm for accurate estimation of SNP allele frequencies in small equimolar pools of DNA using data from high density microarrays. Nucleic Acids Res (2005) 1.50
Efficiency of single-nucleotide polymorphism haplotype estimation from pooled DNA. Proc Natl Acad Sci U S A (2003) 1.27
Methodological Issues in Multistage Genome-wide Association Studies. Stat Sci (2009) 1.06
A survey on haplotyping algorithms for tightly linked markers. J Bioinform Comput Biol (2008) 1.06
Bias, efficiency, and agreement for group-testing regression models. J Stat Comput Simul (2009) 1.02
Allelotyping of pooled DNA with 250 K SNP microarrays. BMC Genomics (2007) 0.93
SNP haplotype tagging from DNA pools of two individuals. BMC Bioinformatics (2003) 0.78
Testing linkage disequilibrium from pooled DNA: a contingency table perspective. Stat Med (2008) 0.75
Excess deaths associated with underweight, overweight, and obesity. JAMA (2005) 22.17
Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA (2007) 11.50
Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet (2010) 9.07
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst (2006) 4.95
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA (2012) 3.85
Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst (2005) 3.75
A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet (2010) 3.53
Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst (2006) 3.36
Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst (2003) 3.07
Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst (2005) 3.07
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol (2008) 2.56
A prospective study of red and processed meat intake in relation to cancer risk. PLoS Med (2007) 2.49
Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst (2003) 2.48
Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst (2009) 2.43
Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology (2002) 2.38
Gail model for prediction of absolute risk of invasive breast cancer: independent evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition cohort. J Natl Cancer Inst (2006) 2.37
Confirmation of family cancer history reported in a population-based survey. J Natl Cancer Inst (2011) 2.13
Haplotype analysis in population genetics and association studies. Pharmacogenomics (2003) 2.13
Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers. Breast Cancer Res Treat (2014) 2.10
Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older. J Clin Oncol (2011) 2.00
Case-control and case-only designs with genotype and family history data: estimating relative risk, residual familial aggregation, and cumulative risk. Biometrics (2006) 1.94
Risk factor modification and projections of absolute breast cancer risk. J Natl Cancer Inst (2011) 1.94
Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants. Proc Natl Acad Sci U S A (2011) 1.93
Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst (2012) 1.88
Data use under the NIH GWAS data sharing policy and future directions. Nat Genet (2014) 1.82
Cancer in Korean war navy technicians: mortality survey after 40 years. Am J Epidemiol (2002) 1.66
Familial aggregation of Hodgkin lymphoma and related tumors. Cancer (2004) 1.60
Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol (2008) 1.59
Validation of a model of lung cancer risk prediction among smokers. J Natl Cancer Inst (2006) 1.55
Correcting bias, or biased corrections? Obesity (Silver Spring) (2008) 1.54
Estrogen metabolism and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2012) 1.53
Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men. J Natl Cancer Inst (2005) 1.51
Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst (2011) 1.51
An ontology-driven semantic mashup of gene and biological pathway information: application to the domain of nicotine dependence. J Biomed Inform (2008) 1.50
Impact of smoking and preexisting illness on estimates of the fractions of deaths associated with underweight, overweight, and obesity in the US population. Am J Epidemiol (2007) 1.46
Understanding the factors underlying disparities in cancer screening rates using the Peters-Belson approach: results from the 1998 National Health Interview Survey. Med Care (2004) 1.46
Using cases to strengthen inference on the association between single nucleotide polymorphisms and a secondary phenotype in genome-wide association studies. Genet Epidemiol (2010) 1.43
Assessment of the human faecal microbiota: II. Reproducibility and associations of 16S rRNA pyrosequences. Eur J Clin Invest (2012) 1.43
Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk. Cancer Res (2002) 1.42
Genetic research and smoking behavior. JAMA (2007) 1.42
Candidate single nucleotide polymorphism selection using publicly available tools: a guide for epidemiologists. Am J Epidemiol (2006) 1.37
Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer (2004) 1.36
Comparing breast cancer risk assessment models. J Natl Cancer Inst (2010) 1.35
Sample size calculations for population- and family-based case-control association studies on marker genotypes. Genet Epidemiol (2003) 1.34
Increasing breast cancer incidence in China: the numbers add up. J Natl Cancer Inst (2008) 1.32
Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes Control (2007) 1.28
Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin Cancer Res (2003) 1.27
Estimation of attributable number of deaths and standard errors from simple and complex sampled cohorts. Stat Med (2007) 1.26
Helicobacter pylori infection in rural China: demographic, lifestyle and environmental factors. Int J Epidemiol (2002) 1.26
Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control (2011) 1.25
Postdiagnosis diet quality is inversely related to a biomarker of inflammation among breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2010) 1.25
Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control (2010) 1.21
Robust genomic control for association studies. Am J Hum Genet (2005) 1.20
Using the Peters--Belson method to measure health care disparities from complex survey data. Stat Med (2005) 1.17
Genomic control for association studies under various genetic models. Biometrics (2005) 1.15
Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers. J Clin Oncol (2012) 1.15
Haplotype-based regression analysis and inference of case-control studies with unphased genotypes and measurement errors in environmental exposures. Biometrics (2007) 1.15
Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. PLoS Med (2013) 1.11
Diet and stomach cancer risk in Warsaw, Poland. Nutr Cancer (2004) 1.09
Garlic, vitamin, and antibiotic treatment for Helicobacter pylori: a randomized factorial controlled trial. Helicobacter (2007) 1.08
Beyond recreational physical activity: examining occupational and household activity, transportation activity, and sedentary behavior in relation to postmenopausal breast cancer risk. Am J Public Health (2010) 1.03
Relationships between computer-extracted mammographic texture pattern features and BRCA1/2 mutation status: a cross-sectional study. Breast Cancer Res (2014) 1.02
Efficient adaptively weighted analysis of secondary phenotypes in case-control genome-wide association studies. Hum Hered (2012) 1.01
Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer. Breast Cancer Res Treat (2010) 1.00
Evaluating breast cancer risk projections for Hispanic women. Breast Cancer Res Treat (2011) 0.99
Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS. J Acquir Immune Defic Syndr (2002) 0.99
Comparison of asbestos exposure assessments by next-of-kin respondents, by an occupational hygienist, and by a job-exposure matrix from the National Occupational Hazard Survey. Am J Ind Med (2005) 0.99
Estimating the variance of disease-prevalence estimates from population-based registries. Biometrics (2002) 0.98
Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China. Carcinogenesis (2013) 0.97
Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study. J Clin Oncol (2010) 0.96
On estimation of the variance in Cochran-Armitage trend tests for genetic association using case-control studies. Stat Med (2006) 0.96
Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. Radiat Res (2009) 0.94
Supplementing high-density SNP microarrays for additional coverage of disease-related genes: addiction as a paradigm. PLoS One (2009) 0.94
Weight-associated deaths in the United States. J Womens Health (Larchmt) (2007) 0.94
Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med (2012) 0.94
Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families. Lancet Oncol (2007) 0.94
Assessment of the human faecal microbiota: I. Measurement and reproducibility of selected enzymatic activities. Eur J Clin Invest (2012) 0.92
Piecewise exponential survival times and analysis of case-cohort data. Stat Med (2012) 0.92
Sensitivity analysis for trend tests: application to the risk of radiation exposure. Biostatistics (2005) 0.92
Absolute risk models for subtypes of breast cancer. J Natl Cancer Inst (2007) 0.91
Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival. Cancer Res (2009) 0.90
A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins. Am J Clin Nutr (2006) 0.90
Sources of differences in estimates of obesity-associated deaths from first National Health and Nutrition Examination Survey (NHANES I) hazard ratios. Am J Clin Nutr (2010) 0.90
Predicting the absolute risk of dying from colorectal cancer and from other causes using population-based cancer registry data. Stat Med (2011) 0.89
Bayesian inference for prevalence and diagnostic test accuracy based on dual-pooled screening. Biostatistics (2005) 0.89
Genetic polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the risk of advanced precancerous gastric lesions in a Chinese population. Cancer Epidemiol Biomarkers Prev (2005) 0.89
Five-year and lifetime risk of breast cancer among U.S. subpopulations: implications for magnetic resonance imaging screening. Cancer Epidemiol Biomarkers Prev (2010) 0.88
The importance of test positive predictive value in ovarian cancer screening. Clin Cancer Res (2008) 0.88
Secular stability and reliability of measurements of the percentage of dense tissue on mammograms. Cancer Detect Prev (2003) 0.87
Robustness of inference on measured covariates to misspecification of genetic random effects in family studies. Genet Epidemiol (2003) 0.87
A method of assessing the sensitivity of the Cochran-Mantel-Haenszel test to an unobserved confounder. Philos Trans A Math Phys Eng Sci (2008) 0.87
Association of fecal microbial diversity and taxonomy with selected enzymatic functions. PLoS One (2012) 0.86
Twenty-five years of breast cancer risk models and their applications. J Natl Cancer Inst (2015) 0.86
Setting priorities for genomic research. Science (2004) 0.86
Strategies for developing prediction models from genome-wide association studies. Genet Epidemiol (2013) 0.85
Predicting the future of genetic risk prediction. Cancer Epidemiol Biomarkers Prev (2011) 0.85